Gold Drifts From Flatline Amidst Fed Jitters

By RTTNews Staff Writer   ✉   | Published:

Prices of the yellow metal edged lower on Wednesday amidst uncertainty over the Fed's future rate hikes and hopes of a pause signal. While the Fed is widely expected to raise rated by 25 basis points in the current review, markets are still guessing how the Fed would strike a balance between financial stability and price stability, going forward.

The Dollar Index (DXY), a measure of the Dollar's relative strength against a basket of six currencies dropped 0.33 percent overnight to 101.62. The day's range was between a low of 101.50 and a high of 101.92. The Dollar's weakness however did not suffice to firm up the prices of the yellow metal.

Fresh indications of stress in the U.S. banking sector also did not suffice to convincingly lift the prices of the yellow metal.

Gold Futures for June Settlement shed 0.12 percent to trade at $2,020.95. The day's trading range has been between $2,017.20 and $2,028.30.

Spot Gold has lost 0.16 percent to trade at $2,013.56 per troy ounce. The day's trading range has been between $2,008.40 and $2,019.57.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
While reporting financial results for the first quarter on Wednesday, Kraft Heinz Co. (KHC) raised its adjusted earnings guidance for the full-year 2023, while reaffirming annual organic net sales growth outlook. For fiscal 2023, the company now projects adjusted earnings in a range of $2.83 to $2.91... Schnuck Markets, Inc. is recalling select containers of Culinaria Nut Mixes citing mislabeling and the potential to contain undeclared almonds, a known allergen, the U.S. Food and Drug Administration said. The recall includes Culinaria Cashew & Macadamia Mix 9 oz. with UPC: 4131822428, Best by date: 2/02/25, and Lot Code: 3033 A9; as well as Culinaria Cashew & Almond Mix 9 oz. with UPC: 413182242 Elanco Animal Health Inc. announced that the U.S. Department of Agriculture or USDA has issued a conditional license for its Canine Parvovirus Monoclonal Antibody. The company expects to begin shipping Canine Parvovirus Monoclonal Antibody in the coming weeks, pending individual state approvals. The targeted single-dose monoclonal antibody is the first and only approved targeted therapeutic...